ATE348837T1 - Neue 14- und 15-gliedrige ringverbindungen - Google Patents

Neue 14- und 15-gliedrige ringverbindungen

Info

Publication number
ATE348837T1
ATE348837T1 AT04732108T AT04732108T ATE348837T1 AT E348837 T1 ATE348837 T1 AT E348837T1 AT 04732108 T AT04732108 T AT 04732108T AT 04732108 T AT04732108 T AT 04732108T AT E348837 T1 ATE348837 T1 AT E348837T1
Authority
AT
Austria
Prior art keywords
new
link ring
ring connections
connections
link
Prior art date
Application number
AT04732108T
Other languages
German (de)
English (en)
Inventor
Sulejman Alihodzic
John Michael Berge
Richard Lewis Jarvest
Original Assignee
Glaxo Group Ltd
Pliva Istrazivacki Inst D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0310962A external-priority patent/GB0310962D0/en
Priority claimed from GB0407391A external-priority patent/GB0407391D0/en
Application filed by Glaxo Group Ltd, Pliva Istrazivacki Inst D O O filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE348837T1 publication Critical patent/ATE348837T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT04732108T 2003-05-13 2004-05-11 Neue 14- und 15-gliedrige ringverbindungen ATE348837T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0310962A GB0310962D0 (en) 2003-05-13 2003-05-13 Novel compounds
GB0407391A GB0407391D0 (en) 2004-03-31 2004-03-31 Novel compounds

Publications (1)

Publication Number Publication Date
ATE348837T1 true ATE348837T1 (de) 2007-01-15

Family

ID=33454579

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04732108T ATE348837T1 (de) 2003-05-13 2004-05-11 Neue 14- und 15-gliedrige ringverbindungen

Country Status (15)

Country Link
US (1) US20070293472A1 (da)
EP (1) EP1628989B1 (da)
JP (1) JP2006528667A (da)
AR (1) AR044304A1 (da)
AT (1) ATE348837T1 (da)
CA (1) CA2525455A1 (da)
CL (1) CL2004001012A1 (da)
DE (1) DE602004003809T2 (da)
DK (1) DK1628989T3 (da)
ES (1) ES2278319T3 (da)
HR (1) HRP20070094T3 (da)
PL (1) PL1628989T3 (da)
PT (1) PT1628989E (da)
SI (1) SI1628989T1 (da)
WO (1) WO2004101587A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2552682T3 (es) 2003-03-10 2015-12-01 Merck Sharp & Dohme Corp. Agentes antibacterianos novedosos
WO2005108412A1 (en) * 2004-05-06 2005-11-17 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ester linked macrolides useful for the treatment of microbial infections
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
EP1879903A1 (en) 2005-05-10 2008-01-23 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Ether linked macrolides useful for the treatment of microbial infections
EP1951735A1 (en) * 2005-11-09 2008-08-06 Glaxo Group Limited New 4*-substituted erythromycin derivative
WO2007054296A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited Macrolones
WO2009055557A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
WO2010048601A1 (en) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
AU2010292010B2 (en) 2009-09-10 2016-01-07 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
RU2608390C2 (ru) 2010-05-20 2017-01-18 Семпра Фармасьютикалз, Инк. Способы получения макролидов и кетолидов, и промежуточных соединений для их получения
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ,インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
RU2658050C2 (ru) 2012-03-27 2018-06-19 Семпра Фармасьютикалз, Инк. Парентеральные составы для введения макролидных антибиотиков
US9861616B2 (en) 2013-03-14 2018-01-09 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US4686207A (en) * 1985-11-12 1987-08-11 Abbott Laboratories Erythromycin A 11,12-carbonates and method of use
ES2080140T3 (es) * 1989-03-28 1996-02-01 Abbott Lab Derivados de eritromicina.
AU3710695A (en) * 1995-04-27 1996-11-18 Laboratorios Aranda, S.A. De C.V. Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them
WO1997042205A1 (en) * 1996-05-07 1997-11-13 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
JP4311203B2 (ja) * 2001-08-08 2009-08-12 大正製薬株式会社 11a−アザライド化合物及びその製造方法
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
DK1628989T3 (da) 2007-10-08
DE602004003809T2 (de) 2007-10-11
WO2004101587A1 (en) 2004-11-25
SI1628989T1 (sl) 2007-06-30
CA2525455A1 (en) 2004-11-25
PT1628989E (pt) 2007-03-30
ES2278319T3 (es) 2007-08-01
US20070293472A1 (en) 2007-12-20
CL2004001012A1 (es) 2005-03-18
EP1628989A1 (en) 2006-03-01
AR044304A1 (es) 2005-09-07
EP1628989B1 (en) 2006-12-20
PL1628989T3 (pl) 2007-05-31
DE602004003809D1 (de) 2007-02-01
JP2006528667A (ja) 2006-12-21
HRP20070094T3 (en) 2008-05-31

Similar Documents

Publication Publication Date Title
DE60212233D1 (de) Zusammengesetzte Farbstoff-Partikel
DE10295851T1 (de) Dachfensterbaueinheit und Einzelteile
DE60328671D1 (de) Neue aminobenzamidderivate
DE60204105D1 (de) Wärmeverträgliche Dichtung
DE60233444D1 (de) Teileanbringvorrichtung und teileanbringverfahren
DE60316588D1 (de) Neue lactame und deren verwendungen
ATE348837T1 (de) Neue 14- und 15-gliedrige ringverbindungen
DE60230883D1 (de) Neue formulierungen und ihre verwendung
DE60336306D1 (de) Photoinitiator, neue verbindung und photohärtbare zusammensetzung
DK1239199T3 (da) Ventilindretning
DE50205152D1 (de) Abgasturbolader
ATE341560T1 (de) Neue 14- und 15-gliedrige ringverbindungen
DE60334907D1 (de) Neue phthalamidderivate
DE60203475D1 (de) Drosselklappe und Drossel
ATE450543T1 (de) Neue 14- und 15-gliedrige ringverbindungen
ATE378347T1 (de) Neue 14- und 15-gliedrige ringverbindungen
DE50309081D1 (de) Neue diketopyrrolopyrrolpigmente
ATE431144T1 (de) Neue formulierungen und ihre verwendung
FR2863143B3 (fr) Releveur d'epis
DE50201746D1 (de) Prothese
DE60219418T8 (de) Silanylphenole und -naphthole
DE50110146D1 (de) Dichtungsanordnung
DE60233952D1 (de) Neue serinprotease
ITRM20010077V0 (it) Linea alcione
ITRM20010074V0 (it) Linea arabel

Legal Events

Date Code Title Description
EEFA Change of the company name
UEP Publication of translation of european patent specification

Ref document number: 1628989

Country of ref document: EP

REN Ceased due to non-payment of the annual fee